Laurion Capital Management LP Reata Pharmaceuticals Inc Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$94.25 - $132.81 $943,254 - $1.33 Million	-10,008 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $1.02 Million - $1.85 Million	10,008 New	10,008 $1.24 Million
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $808,192 - $1.41 Million	-8,641 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $1.09 Million - $1.53 Million	8,641 New	8,641 $1.35 Million
Q2 2018 Aug 13, 2018	SELL	$19.94 - $40.96 $3.21 Million - $6.6 Million	-161,139 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$20.0 - $30.19 $7.14 Million - $10.8 Million	-356,952 Reduced 68.9%	161,139 $3.31 Million
Q4 2017 Feb 13, 2018	BUY	$22.39 - $33.27 $11.6 Million - $17.2 Million	518,091	518,091 $14.7 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.